Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers. San Francisco, CA – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases […]
Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Fremont, CA, US and Cambridge, UK – Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, […]
LAS VEGAS — GeneASIC Applied sciences might be strolling into this 12 months’s CES 2022 arm in arm with its first product, the GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform (NGSAAP). The annual occasion deemed probably the most influential tech occasion and is a showcase of the most recent innovation in design and engineering within the client know-how […]
The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twist Bioscience for rare disease diagnostics CentoCloud provides rapid and reliable medical […]
eureKARE participatesin DNA Script’s $200 Million Series C Financing Fundraisewill accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France – eureKARE (“the Company”), a pioneering company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, is pleased to announce that it has participated in DNA Script’s […]
CAMBRIDGE, Mass. — Erbi Biosystems, developer of innovative, small-scale, automated, and high-performance cell culture systems, has closed a private round of funding totaling $4M. This latest financing will enable the company to expand operations to meet the growing demand for its Breez perfusion bioreactor product and develop extensions to enhance cell therapy applications. The Erbi Breez bioreactor provides […]
BBI Solutions, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has today announced the acquisition of “Biotez”. BioTeZ Berlin-Buch GmbH (also including Steffens Biotechnische Analysen GmbH), is a Germany-based manufacturer of reagents and finished tests for the In-Vitro Diagnostics (“IVD”) market, as well as components for the food safety market. The acquisition […]
Houston, TX — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on ChiNext (SZSE: 301047), provides biological research reagents and related technical contract research services, is pleased to announce its physical geographic expansion, adding a new location in Houston, Texas. With the company’s headquarters in Beijing, China and subsidiaries in Suzhou […]
Chemopharm invests in Malaysian medical equipment distributor Medigene Sdn. Bhd. Kuala Lumpur – Chemopharm Sdn. Bhd. (“Chemopharm”), an Everlife company and leading laboratory supplies and IVD distributor in Malaysia, has announced the completion of its investment of another Malaysian medical equipment distributor, Medigene Sdn. Bhd. (“Medigene”). Founded in Oct 2000, Medigene supplies laboratories nationwide with […]
Agreement strengthens the accessibility of Tapestri Platform and Services for oncology research, clinical assay development, and data analysis capabilities in China, accelerating clinical adoptions through collaborative efforts GUANGZHOU, China and SOUTH SAN FRANCISCO, Calif. — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with SequMed, a pioneer in single-cell omics technology […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
